Hội chứng thận nhiễm mỡ bẩm sinh và sự tái phát protein niệu sau cấy ghép thận

Jalanko H, Holmberg C (2009) Congenital nephrotic syndrome. In: Avner D-D, Harmon W-E, Niaudet P, Yoshikawa N (eds) Pediatric Nephrology, 6th edn. Springer, Berlin Heidelberg New York, pp S601–S619 Agati VD, Kaskel FJ, Falk RJ (2011) Focal segmental glomerulosclerosis. N Engl J Med 365:2398–2411 Ahvenainen EK, Hallman N, Hjelt L (1956) Nephrotic syndrome in newborn and young infants. Ann Paediatr Fenn 2:227–241 Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K (1998) Positionally cloned gene for a novel protein—nephrin—is mutated in congenital nephrotic syndrome. Mol Cell 1:575–582 Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestilä M, Jalanko H, Holmberg C, Tryggvason K (1999) Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 96:7962–7967 Patrakka J, Tryggvason K (2007) Nephrin—a unique structural and signalling protein of the kidney filter. Trends Mol Med 13:396–403 Patrakka J, Kestilä M, Wartiovaara J, Ruotsalainen V, Tissari P, Lenkkeri U, Männikkö M, Visapää I, Holmberg C, Rapola J, Tryggvason K, Jalanko H (2000) Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int 58:972–980 Holmberg C, Antikainen M, Rönnholm K, Ala-Houhala M, Jalanko H (1995) Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 9:87–93 Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349–354 Machuca E, Benoit G, Nevo F, Tête M-J, Gribouval O, Pawtowski A, Brandström P, Loirat C, Niaudet P, Gubler M-C, Antignac C (2010) Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome. J Am Soc Nephrol 21:1209–1217 Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F, members of the Arbeitsgemeinschaft fuer Pediatrische Nephrologie Study group (2007) Nephrotic syndrome in the first year of life: two-thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907–E919 Gbadegesin R, Hinkes BG, Hoskins BE, Vlangos CN, Heeringa SF, Liu J, Loirat C, Ozaltin F, Hashmi S, Ulmer F, Cleper R, Ettenger R, Antingac C, Wiggins RC, Zenker M, Hildebrandt F (2008) Mutations in PLCE1 are major cause of isolated diffuse mesangial sclerosis (IDMS). Nephrol Dial Transplant 23:1291–1297 Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cécille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C (1998) Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 62:824–833 Zenker M, Aigner T, Wendler O, Tralau T, Muntefering H, Fenski R, Pitz S, Schumacher V, Royer-Pokora B, Wuhl E, Cochat P, Bouvier R, Kraus C, Mark K, Madlon H, Dotsch J, Rascher W, Maruniak-Chudek I, Lennert T, Neumann LM, Reis A (2004) Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum Mol Genet 13:2625–2632 Diomedi-Camassei F, Di Giandomenico S, Santorelli FM, Cardini G, Piemonte F, Montini G, Ghiggeri GM, Murer L, Barisoni L, Pastore A, Muada AO, Valente ML, Bertini E, Emma F (2007) COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 18:2773–2780 Heeringa S, Chernin G, Chaki M, Zhou W, Sloan AJ, Ji Z, Xie LX, Salviati L, Hurd TW, Vega-Warner V, Killen PD, Raphael Y, Ashraf S, Ovunc B, Schoeb DS, McLaughlin HM, Airik R, Vlangos CN, Gbadegesin R, Hinkes B, Saisawat P, Trevisson E, Doimo M, Casarin A, Pertegato V, Giorgi G, Prokisch H, Rötig A, Nuernberg G, Becker C, Wang S, Ozaltin F, Topaloglu R, Bakkaloglu A, Bakkaloglu SA, Mueller D, Beissert A, Mir S, Berdeli A, Özen S, Zenker M, Matejas V, Santos-Ocaña C, Navas P, Kusakabe T, Kispert A, Akman S, Soliman NA, Krick S, Mundel P, Reiser J, Nuernberg P, Clarke CF, Wiggins RC, Faul C, Hildebrandt F (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest 121:2013–2024 Gupta IR, Baldwin C, Auguste D, Ha KCH, Andalousi JE, Fahimiya S, Bitzan M, Bernard C, Akbari MR, Narod SA, Rosenblatt DS, Majewski J, Takano T (2013) ARGHDIA: a novel gene implicated in nephrotic syndrome. J Med Genet 50:330–338 Gee HY, Saisawat P, Ashraf S, Hurd TW, Vega-Werner V, Fang H, Beck BB, Gribouval O, Zhou W, Diaz KA, Natarajan S, Wiggins RC, Lovric S, Chernin G, Schoeb DS, Uvunc B, Frishberg Y, Soliman NA, Fathy HM, Goebel H, Hoefele J, Weber LT, Innis JW, Faul C, Han Z, Washburn J, Antignac C, Levy S, Otto EA, Hildebrandt F (2013) ARGHDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest 123:3243–3253 Smith JM, Matz K, Blydt-Hansen TD (2013) Pediatric kidney transplant practice patterns and autcome benchmarks, 1987–2010: A report of the North American Pediatric Renal Trials and Collaborative Studies. Pediatr Transplant 17:149–157 Foster BJ, Dahhou M, Zhang X, Platt RW, Samuel SM, Hanley JA (2011) Association between age and graft failure rates in young kidney transplant recipients. Transplantation 92:1237–1243 Hertelius M, Celsi G, Edström Halling S, Krmar RT, Sandberg J, Tydén G, Åsling- Monemi K, Berg U (2012) Renal transplantation in infants and small children. Pediatr Nephrol 27:145–150 Patzer RE, Amaral S, Klein M, Kutner N, Perryman JP, Gazmararian JA, McCellan WM (2012) Racial disparities in pediatric access to kidney transplantation: does socioeconomic status play a role? Am J Transplant 12:369–378 Gondos A, Döhler B, Brenner H, Opelz G (2013) Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation 95:267–274 Salvatierra O Jr, Singh T, Shiffrin R, Conley S, Alexander S, Tanney D, Lemley K, Sarwal M, Mackie F, Alfrey E, Orlandi P, Zarins C, Hefkens R (1998) Successful transplantation of adult-size kidneys into infants requires maintenance of high aortic blood flow. Transplantation 66:819–823 Mehls O, Fine RN (2013) Growth hormone treatment after renal transplantation: a promising but underused chance to improve growth. Pediatr Nephrol 28:1–4 Tainio J, Qvist E, Vehmas R, Jahnukainen K, Hölttä T, Valta H, Jahnukainen T, Jalanko H (2011) Pubertal development is normal in adolescents after renal transplantation in childhood. Transplantation 92:404–409 Laakkonen H, Taskinen S, Rönnholm K, Holmberg C, Sandberg S (2014) Parent-child and spousal relationship in families with a young child with end-stage renal disease. Pediatr Nephrol 29:289–295 Kumar J, Shatat IF, Skversky AL, Woroniecki RP, Del Rio M, Perelstein EM, Johnson VL, Mahesh S (2013) Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis. Pediatr Nephrol 28:333–338 Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Luca M, Emma F, Sanna- Cherchi S, Scolari F, Neri TM, Murer L, Massella L, Basile G, Rizzoni G, Perfumo F, Ghiggeri GM (2003) Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41:1314–1321 Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chadhuri A, Daftarin P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerusclerosis. Nat Med 17:952–960 Bitzan M, Babayeva S, Vasudevan A, Goodyear P, Torban E (2012) TNFα pathway blockade ameliorate toxic effects of FSGS plasma on podocyte cytoskeleton and 3 integrin activation. Pediatr Nephrol 27:2217–2226 Laine J, Jalanko H, Holthöfer H, Krogerus L, Rapola J, von Willebrand E, Lautenschlager I, Salmela K, Holmberg C (1993) Post-transplant nephrosis in congenital nephrotic syndrome of the Finnish type. Kidney Int 44:867–874 Sigström L, Hansson S, Jodal U (1989) Long-term survival of a girl with congenital nephrotic syndrome and recurrence of proteinuria after transplantation (abstr). Pediatr Nephrol 3:C169 Lane PH, Schnaper HW, Vernier RL, Bunchman TE (1991) Steroid-dependent nephrotic syndrome following renal transplantation for congenital nephrotic syndrome. Pediatr Nephrol 5:300–303 Flynn JT, Schulman SL, Dechaderevian J-P, Dunn SP, Kaiser BA, Polinsky MS, Baluarte HJ (1992) Treatment of steroid-resistant post-transplant nephrotic syndrome with cyclophosphamide in a child with congenital nephrotic syndrome. Pediatr Nephrol 6:553–555 Patrakka J, Ruotsalainen V, Reponen P, Qvist E, Laine J, Holmberg C, Tryggvason K, Jalanko H (2002) Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type. Transplantation 73:394–403 Kashtan CE (1999) Alport syndrome: an inherited disorder of renal, ocular and cochlear basement membranes. Medicine 78:338–360 Kuusniemi A-M, Qvist E, Sun Y, Patrakka J, Rönnholm K, Karikoski R, Jalanko H (2007) Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type. Transplantation 83:1316–1323 Srivastava T, Garola RE, Kestilä M, Tryggvason K, Ruotsalainen V, Sharma M, Savin V, Jalanko H, Warady B (2006) Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 21:711–718 Chauduri A, Kambham N, Sutherland S, Grimm P, Alexander S, Conception W, Sarwal M, Wong C (2012) Rituximab treatment for recurrence of nephrotic syndrome in a paediatric patient after renal transplantation for congenital nephrotic syndrome of the Finnish type. Pediatric Transplant 16:E183–E187 Billing H, Muller D, Ruf R, Lichtenberger A, Hildebrandt F, August C, Querfeld U, Haffner D (2004) NPHS2 mutation associate with recurrence of proteinuria after transplantation. Pediatr Nephrol 19:561–564 Becker-Cohen R, Bruschi M, Rinat C, Feinstein S, Zennaro C, Ghicceri G, Frishberg Y (2007) Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am J Transplant 7:256–260 Weber S, Gribouval O, Esquivel E, Moriniere V, Tete M, Legendre C, Niaudet P, Antignac C (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66:571–579 Höcker B, Knuppel T, Waldherr R, Schaefer F, Weber S, Tönshoff B (2006) Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr Nephrol 21:1476–1479 Carraro M, Caridi G, Bruschi M, Arter M, Bertelli R, Zennaro C, Musante L, Candiano G, Perfumo F, Ghiggeri G (2002) Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13:1946–1952 Niaudet P (2010) Living donor kidney transplantation in patients with hereditary nephropathies. Nat Rev Nephrol 6:736–743